NCT05718297
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05718297 |
| Title | Brigatinib Post Definitive Chemo-radiotherapy in Patients With ALK-fusion Non-small Cell Lung Cancer (BOUNCE) |
| Acronym | BOUNCE |
| Recruitment | Withdrawn |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | ETOP IBCSG Partners Foundation |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | POL | ITA | GBR | FRA | ESP |
CKB BOOST